Learn the latest on Illumina's acquisition of GRAIL and what each regulatory milestone and development means for the future of preventing, detecting, and treating cancer.

News

September 5, 2023

How a federal agency’s blocking of a company merger threatens cancer care for veterans

The San Diego Union-Tribune

June 29, 2023

The FTC’s double standard is threatening America’s health, innovation, and patients

Washington Examiner

June 13, 2023

GOP Lawmakers, AGs Back Illumina Against FTC At 5th Circ.

Law360

June 7, 2023

Biden’s FTC is blocking a game-changer for cancer patients

The Hill

June 6, 2023

Merger cops’ sandcastle arguments risk crumbling

Reuters Breakingviews

April 28, 2023

Lina Khan Blocks Cancer Cures

The Wall Street Journal

April 15, 2023

FTC rules in its own favor and against cancer patients

Washington Times

April 4, 2023

A big test for Biden’s antitrust cops | The FTC is wrong about Illumina

Semafor Business

April 4, 2023

Illumina battle with regulators threatens cancer breakthrough, warn Grail alumni

Financial Times

April 3, 2023

The FTC’s Unholy Antitrust Grail

The Wall Street Journal

February 23, 2023

The FTC’s Antitrust Collusion

The Wall Street Journal

November 23, 2022

Private Sector is Key to Landing Biden’s Cancer Moonshot

Boston Business Journal

March 21, 2022

Could Biden’s FTC trip up his cancer moonshot?

POLITICO’s West Wing Playbook

January 28, 2022

Biden Renews Pushback Against Stock Buybacks

New York Times DealBook

January 26, 2022

Illumina Will Seek to Overcome EU Antitrust Concerns Over Grail Deal, CEO Says

MLex

January 16, 2022

Illumina Says EU Probe of $8BN Grail Deal Could Hit Biotech Investment

Financial Times

December 8, 2021

Regulatory Hurdles Block a Cancer Miracle

WSJ

August 18, 2021

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

Press Release

March 30, 2021

Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test

Press Release

September 20, 2020

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Press Release